Royal Bank of Canada Analysts Give Siemens Healthineers (ETR:SHL) a €42.00 Price Target

Royal Bank of Canada set a €42.00 ($49.41) price target on Siemens Healthineers (ETR:SHL) in a research note released on Friday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

SHL has been the subject of a number of other research reports. Independent Research set a €39.00 ($45.88) price target on Siemens Healthineers and gave the company a neutral rating in a research report on Friday, September 4th. Nord/LB set a €52.00 ($61.18) target price on shares of Siemens Healthineers and gave the stock a buy rating in a research report on Tuesday, August 4th. Barclays set a €39.00 ($45.88) price target on shares of Siemens Healthineers and gave the company a neutral rating in a research report on Monday, October 5th. Deutsche Bank Aktiengesellschaft set a €40.00 ($47.06) price objective on shares of Siemens Healthineers and gave the stock a neutral rating in a research report on Monday, August 3rd. Finally, Sanford C. Bernstein set a €47.00 ($55.29) price target on shares of Siemens Healthineers and gave the stock a buy rating in a research report on Monday, September 28th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have issued a buy rating to the company’s stock. The company presently has an average rating of Hold and an average price target of €42.37 ($49.85).

ETR:SHL opened at €37.67 ($44.31) on Friday. The firm has a market capitalization of $37.64 billion and a PE ratio of 25.80. The company has a debt-to-equity ratio of 56.67, a current ratio of 1.31 and a quick ratio of 0.79. The business’s fifty day moving average price is €37.72 and its 200 day moving average price is €40.60. Siemens Healthineers has a 12 month low of €28.50 ($33.53) and a 12 month high of €47.27 ($55.61).

About Siemens Healthineers

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Read More: What are the benefits of a portfolio tracker?

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.